🇺🇸 FDA
Patent

US 11938177

Peptide vaccine formulations and use thereof for inducing an immune response

granted A61KA61K2039/555A61K2039/55555

Quick answer

US patent 11938177 (Peptide vaccine formulations and use thereof for inducing an immune response) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/555, A61K2039/55555, A61K2039/60, A61K2039/6093